Biotechnology Regeneron/Sanofi’s Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation – Regeneron Pharmaceuticals (NASDAQ:REGN), Sanofi (NASDAQ:SNY) Read more